We treated a 57-year-old woman fo r ranula. After aspirating the cyst's contents, we admini stered 0.1 KE/ml of OK-432 via local injection. One month later, the cyst had still persisted, so we repeated the procedure. After 2 weeks, the ranula began to shrink markedly, and at 4 weeks it had almost disappeared. No recurrence of the ranula was observed during the subsequent I year of fo llow-up. Following each inj ection, the patient developed transient feve r and local swelling but no serio us complications. Our expe rience suggests that OK-432 injection is an effective treatment for ranula. However, because this treatment causes the cyst to collapse rather than disapp ear completely, patients should be regularly monitored over the long term.
Introduction
A ranula is a type of retenti on cys t that occurs on the floor of the mouth or underside ofthe tongue, usually as a result of an obstruction in the ducts of the submaxillary or sublingual salivary glands. Surgical excision has been considered the definitive treatment in most cases. However, complete excision is sometimes difficult because the cyst wall is very thin , especially in larger cysts. Moreover, surgical complica tions, such as nerve injur y and cos metic problems, can occ ur.
To avo id these probl ems, the surgeon has the opti on of treating a ranula with an injection of a sclerosing age nt. In this article, we descr ibe a case of ranu la that we successfully treated with locally injected OK-4 32.
Case report
We eval uated a 57-year-old woman who had first noticed swelling of the oral floor in October 1999. At that time, she went to an ENT clinic in her neighborhood, where she was treated with antibiotics. When the size of the mass did In January 2000 , we aspirated the conten ts of the cyst (7 ml) and injected 0.1 KE/ml of OK-432. The patient exper ienced some postinjection feve r and local swelling, which abated after 2 days. The wall of the cyst gradually hardened and the cyst began to shrink somewhat. However, I month later, the cyst was still noticeable .
In Februa ry 2000 , we aga in aspirated the cyst (5 ml) and injected another O.I-KE/ml dose of OK-432. The resultant fever and local swelling resolved after 3 days. Between 2 and 4 week s later, the size of the cyst had decre ased markedly ( figure 3 ). Follow-up T2-weighted MRI showed that the area of high signal inten sity was limited only to the left side of the oral floor ( figure 4) . We informed the patient that this finding might indicate a potential for recurrence, but she was satisfied with the result and declined an additional injection. The patient is still under regul ar observation, and the ranula had not recurred durin g I year of follow-up.
Discussion
In 1976, Yura et al first reported the use of sclero sing therapy (with bleomycin) in a patient with cystic hygroma. ' However, bleom ycin can cause several severe side effec ts, including fibros is of the lung.
During the late 1980s, Ogita et al began to administer sclerosing therapy with OK-432 to children with various cystic diseases, prim arily cystic hygrom a of the head and neck , as a way of avoidin g surgical risks such as functional dam age and cosmetic problems.2·4 In all, they found that 27 of 31 cases (87%) of cystic hygroma responded well to therapy. Among the 21 patients who experienced a complete response, IO did so after only one injection. Th e cys ts in the re mai ning II patient s resol ved afte r two to fo ur injecti on s.
Th e active ingredient in OK-432 is the treated cell bod y of St repto co ccus pyo geties (SU strain, gro up A). Th is drug' s bio logic act ivities include act ivation of macrophages and natural killer cells, stim ulation of interferon, and reac tiva tio n of cytok ines.Y Injected OK -432 induces a strong inflammati on and ca uses the cys t walls to adhere to each other during the healing process.
A ranula is similar to a cystic hygrom a in that it has a very thin wall. In view of OK-432's effec tive ness in treating the latter, one would expec t that this age nt might be effective in treating a ranu la, as well. lkara shi et al suggested as much in their case report of 1994. 6 Owing to the fact that our patient' s cyst was large and surgery carried some notable risks, including lingual and hypoglossal nerve injury , we and the patie nt agreed to try OK-432 instead.
Th e ideal time to eva luate whether therapy has been effective is prob ably 4 weeks follow ing adm inistration. In our patient, most of the decrease in the size of the mass took place between 2 and 4 weeks following the second injection. Yoshino and Naka zawa injected OK-432 into a gastric carcinoma under endo scopy and reported that the infiltration of inflammatory cells persisted for 2 week s before the number of ce lls began to gradually decrease.'
Based on our experience, we conclude that sclerosing therapy with OK -432 is an effective treatment for a ranula when surgery might prove to be risky . Side effects are tolerable and tran sient. 
